Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets

Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets Biochem Genet https://doi.org/10.1007/s10528-018-9863-8 REVIEW Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets 1,2 3 4 1,5 Monica Szabó  · Beáta Máté  · Katalin Csép  · Theodora Benedek Received: 20 March 2017 / Accepted: 16 May 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract With the pandemic of type 2 diabetes (T2D), there is an ever-increasing need to fully understand the underlying mechanisms of the disease. Type 2 diabe- tes shows a high heritability risk (25–80%); however, genes account only for 10% of this risk. From all the risk factors for diabetes, epigenetic mechanisms have the highest statistical scoring in explaining the disease. A multitude of organ-specific epigenomic changes have been linked to type 2 diabetes. Nutritional influences, mainly in the early life, physical activity level, environmental toxins act as epige- netic factors and the recognized epigenetic changes can represent a therapeutical target, new drugs being currently in development for this application. Our current review focuses on the most common epigenetic modifications linked to type 2 dia - betes or insulin resistance, the potentially emerging epigenetic-related interventions and pharmacoepigenetic knowledge. Keywords Epigenetics of type 2 diabetes · Nutritional epigenetic effects · DNA methylation · Histone modification, non-coding RNAs · Pharamacoepigenetic * Monica Szabó http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Biochemical Genetics Springer Journals

Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets

Loading next page...
 
/lp/springer_journal/epigenetic-modifications-linked-to-t2d-the-heritability-gap-and-248XB008vm
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Biomedicine; Human Genetics; Biochemistry, general; Zoology; Medical Microbiology
ISSN
0006-2928
eISSN
1573-4927
D.O.I.
10.1007/s10528-018-9863-8
Publisher site
See Article on Publisher Site

Abstract

Biochem Genet https://doi.org/10.1007/s10528-018-9863-8 REVIEW Epigenetic Modifications Linked to T2D, the Heritability Gap, and Potential Therapeutic Targets 1,2 3 4 1,5 Monica Szabó  · Beáta Máté  · Katalin Csép  · Theodora Benedek Received: 20 March 2017 / Accepted: 16 May 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Abstract With the pandemic of type 2 diabetes (T2D), there is an ever-increasing need to fully understand the underlying mechanisms of the disease. Type 2 diabe- tes shows a high heritability risk (25–80%); however, genes account only for 10% of this risk. From all the risk factors for diabetes, epigenetic mechanisms have the highest statistical scoring in explaining the disease. A multitude of organ-specific epigenomic changes have been linked to type 2 diabetes. Nutritional influences, mainly in the early life, physical activity level, environmental toxins act as epige- netic factors and the recognized epigenetic changes can represent a therapeutical target, new drugs being currently in development for this application. Our current review focuses on the most common epigenetic modifications linked to type 2 dia - betes or insulin resistance, the potentially emerging epigenetic-related interventions and pharmacoepigenetic knowledge. Keywords Epigenetics of type 2 diabetes · Nutritional epigenetic effects · DNA methylation · Histone modification, non-coding RNAs · Pharamacoepigenetic * Monica Szabó

Journal

Biochemical GeneticsSpringer Journals

Published: Jun 5, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off